Schedule 13D ownership disclosure

LYRA THERAPEUTICS INC

Security class unavailable · CUSIP: 55234L105

Event date: 2024-08-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-201452
Form type
SC 13D/A
Filer
Lyra Therapeutics, Inc.
CIK
CIK 1327273
Filed
Aug 15, 2024
Reporting period
Aug 14, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub